Ashish Tripathi
Director/Miembro de la Junta en Epigeneres Biotech Pvt Ltd. .
Cargos activos de Ashish Tripathi
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Epigeneres Biotech Pvt Ltd.
Epigeneres Biotech Pvt Ltd. Pharmaceuticals: MajorHealth Technology Epigeneres Biotech Pvt Ltd. is an Indian company that focuses on detecting and treating cancer early. The company is based in Mumbai, India and was founded in 2012 by Anish Tripathi. In addition to their cancer detection technology, they also have a nutraceuticals business that specializes in molecular diagnostics and nutraceutical management for overall health and well-being. The company has developed a breakthrough technology based on the assumption that very small embryonic-like stem cells (VSELs) undergo epigenetic changes and get transformed into cancer stem cells (CSCs). The company's HRC test has the potential to detect cancer at stage zero, which significantly improves the cost, time, and chances of survival. | Director/Miembro de la Junta | 29/02/2016 | - |
Historial de carrera de Ashish Tripathi
Estadísticas
Internacional
India | 2 |
Operativa
Director/Board Member | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Epigeneres Biotech Pvt Ltd.
Epigeneres Biotech Pvt Ltd. Pharmaceuticals: MajorHealth Technology Epigeneres Biotech Pvt Ltd. is an Indian company that focuses on detecting and treating cancer early. The company is based in Mumbai, India and was founded in 2012 by Anish Tripathi. In addition to their cancer detection technology, they also have a nutraceuticals business that specializes in molecular diagnostics and nutraceutical management for overall health and well-being. The company has developed a breakthrough technology based on the assumption that very small embryonic-like stem cells (VSELs) undergo epigenetic changes and get transformed into cancer stem cells (CSCs). The company's HRC test has the potential to detect cancer at stage zero, which significantly improves the cost, time, and chances of survival. | Health Technology |
- Bolsa de valores
- Insiders
- Ashish Tripathi
- Experiencia